Literature DB >> 18175689

Prevotella amnii sp. nov., isolated from human amniotic fluid.

Paul A Lawson1, Edward Moore, Enevold Falsen.   

Abstract

Two Gram-negative, anaerobic, non-spore-forming, rod-shaped organisms were isolated from human amniotic fluid. Based on morphological and biochemical criteria, the strains were tentatively identified as Bacteroidaceae but they did not appear to correspond to any recognized species of this family. Comparative 16S rRNA gene sequencing studies showed the strains were highly related to each other and confirmed their placement in the genus Prevotella, but sequence divergence values of >4% with reference Prevotella species demonstrated that the organisms from human clinical sources represent a novel species. Phylogenetic analysis revealed the novel organism to be most closely related to Prevotella bivia, an organism frequently associated with pelvic inflammatory diseases. The major long-chain cellular fatty acids of the novel species consist of iso-C(14:0), anteiso-C(15:0), iso-C(15:0), C(16:0), iso-C(16:0) and iso-3-OH-C(17:0). Based on biochemical criteria and phylogenetic considerations, it is proposed that the unknown isolates from human amniotic fluid be assigned to a new species of the genus Prevotella, as Prevotella amnii sp. nov. The type strain of Prevotella amnii is CCUG 53648(T) (=JCM 14753(T)).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175689     DOI: 10.1099/ijs.0.65118-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  9 in total

1.  Gardnerella vaginalis and Prevotella bivia Trigger Distinct and Overlapping Phenotypes in a Mouse Model of Bacterial Vaginosis.

Authors:  Nicole M Gilbert; Warren G Lewis; Guocai Li; Dorothy K Sojka; Jean Bernard Lubin; Amanda L Lewis
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

2.  Spinal epidural abscess caused by Gardnerella vaginalis and Prevotella amnii.

Authors:  Leslie Stewart; Saurabh Sinha; Peter J Madsen; Laurel Glaser; H Isaac Chen; Matthew J Culyba
Journal:  Infect Dis Clin Pract (Baltim Md)       Date:  2018-07

3.  Metaphylogenomic and potential functionality of the limpet Patella pellucida's gastrointestinal tract microbiome.

Authors:  Magda Dudek; Jessica Adams; Martin Swain; Matthew Hegarty; Sharon Huws; Joe Gallagher
Journal:  Int J Mol Sci       Date:  2014-10-20       Impact factor: 5.923

4.  Genome-Based Taxonomic Classification of Bacteroidetes.

Authors:  Richard L Hahnke; Jan P Meier-Kolthoff; Marina García-López; Supratim Mukherjee; Marcel Huntemann; Natalia N Ivanova; Tanja Woyke; Nikos C Kyrpides; Hans-Peter Klenk; Markus Göker
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

5.  The potential of metatranscriptomics for identifying screening targets for bacterial vaginosis.

Authors:  Jimmy Twin; Catriona S Bradshaw; Suzanne M Garland; Christopher K Fairley; Katherine Fethers; Sepehr N Tabrizi
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

6.  Non-contiguous finished genome sequence of Prevotella timonensis type strain 4401737(T.).

Authors:  Véronique Roux; Catherine Robert; Didier Raoult
Journal:  Stand Genomic Sci       Date:  2014-02-20

7.  Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women.

Authors:  Paweł Łaniewski; Dominique Barnes; Alison Goulder; Haiyan Cui; Denise J Roe; Dana M Chase; Melissa M Herbst-Kralovetz
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

8.  Prevotella ihumii sp. nov., a new bacterium isolated from a stool specimen of a healthy woman.

Authors:  H Anani; E Guilhot; C Andrieu; A Fontanini; D Raoult; P E Fournier
Journal:  New Microbes New Infect       Date:  2019-10-08

Review 9.  Oral Prevotella Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts.

Authors:  Eija Könönen; Ulvi K Gursoy
Journal:  Front Microbiol       Date:  2022-01-06       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.